Source comparison
How does MK-677 dosage differ for aging populations versus younger subjects?
Aging populations (50+ years) often require higher doses (20–25mg) to achieve comparable IGF-1 elevation compared to younger subjects due to blunted endogenous GH secretory capacity and decreased hepatic IGF-1 synthesis efficiency. A comparative study found th
This comparison does not assign a generated winner or score.
- Aging populations (50+ years) often require higher doses (20–25mg) to achieve comparable IGF-1 elevation compared to younger subjects due to blunted endogenous GH secretory capacity and decreased hepatic IGF-1 synthesis efficiency. A comparative study found that 15mg daily produced mean IGF-1 increases of 70ng/mL in subjects under 35 but only 45ng/mL in subjects over 55, despite equivalent plasma ibutamoren levels. Conversely, younger populations with intact GH pulsatility frequently achieve target IGF-1 ranges at 12.5–15mg, making higher doses unnecessary. Age-stratified dosing protocols. 12.5–15mg for those under 40, 20–25mg for those over 50. Reflect these physiological differences in GH axis responsiveness.